Objective: to make a practical animal model with liver blood stasis caused by pathogenic factor.
来自互联网
2. 结果通过分析，归纳出新疆高脂血症患者中医证型以秽浊痰阻证多见。
Result Phlegm-turbidity syndrome is the main syndrome in hyperlipemia patients of Xinjiang.
来自互联网
3. 结论：心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)安全、有效。
CONCLUSION: Xindakang capsule is an effective and safe drug in treating angina pectoris.
来自互联网
4. 心血瘀阻证、痰阻心脉证和心阴亏虚证等证候为冠心病患者的主要证候特点。
The syndrome types are mostly heart blood stasis syndrome, heart collaterals obstruction due to phlegm accumulation syndrome and heart-Yin deficiency syndrome.
来自互联网
5. 目的：评价心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)的临床疗效与安全性。
AIM: to evaluate the efficacy and safety of xindakang capsules in the treatment of patients with angina pectoris.
来自互联网
6. 目的探讨黄芩正气胶囊治疗湿阻中焦证的作用机理。
Objective To explore the therapeutic mechanism of Huangqin Zhengqi Capsule for the syndrome of damp retention in middle-jiao.
来自互联网
7. 美尼尔氏综合症：研究病例为387例，证型分布为痰浊中阻、肝阳上亢、肝肾两虚、气血亏虚。
Alabyrinthitis of the auris: I had reached 387 cases, the result is: sputum, excessive of the liver-yang, deficiency of liver and kidney, deficiency of qi and blood.
ConclusionQixing pain-relieving plaster has obviously satisfactory effect on rheumatoid, osteoarthritis and cervical and lumbar spondylopathy, especially for the patients with cold-damp syndrome.
来自互联网
9. 目的观察针刺背俞穴为主与常规针刺治疗缺血性中风(瘀血阻络证)的疗效差异。
Objective To compare the efficacy of acupuncture at Back-Shu points as main therapy with conventional acupuncture in treating ischemic stroke (obstruction of channels by stagnant blood).
来自互联网
10. 目的：探讨舌侧去骨法与颊侧去骨法用于拔除下颌水平阻生第三磨牙的适应证。
Objective: To investigate the indication of distolingual and distobuccal alveolectomy in removal of impacted mandibular third molars.
Neck illness that is suffered by the illness of vertebra artery: I had reached 2040 cases, the result is: deficiency of qi and blood, deficiency of liver and kidney, sputum, cold and wet, ecchymosis.
Conclusion: Combined treatment of TCM has superiority to single therapy for patients of acute cerebral infarction with "Wind-Phlegm and Blood Stasis in Collaterals".
Results: frequency of occurrence is as follows stagnated blood (75.8%), deficiency of kidney-YANG (45.9%), humid heat (38.7%).
来自互联网
14. 目的：验证三子咳喘胶囊对慢性支气管炎(痰湿阻肺证)的疗效，并对其安全性作出客观评价。
Objective: To certificate the curative effects of Sanzi Kechuan Capsule in treating chronic bronchitis with syndrome of phlegm-dampness accumulated in the lung, and evaluate objectively its safety.
来自互联网
15. 结果：冠心病中医证型以热证居多，其中以痰热瘀阻型占有绝对优势。
Results: Most of coronary heart diseases belong to heat syndrome, and the type of phlegm-heat and blood stasis is preponderant.
来自互联网
16. 目的：观察银杏内酯注射液治疗中风病中经络瘀血阻络证的临床疗效。
Objective: to observe the clinical effectiveness of the meridional and collateral apoplexy congestion block collateral symptom of apoplexy in the treatment of ginkgolide injection.
The heart blood stasis syndrome is one of the commonest syndrome, the vessel endothelial dysfunction is probably one of characteristics of HBSS in CHD.
来自互联网
18. 目的：观察银杏内酯注射液治疗中风病中经络瘀血阻络证的临床疗效。
To study the clinical curative effects of "Xiaozhongfeng capsules" on stroke precursor caused by phlegm-stasis in channels.
来自互联网
19. 目的：探讨舌侧去骨法与颊侧去骨法用于拔除下颌水平阻生第三磨牙的适应证。
Objective To investigate the indications of distolingual alveolectomy in the removel of impacted mandibular third molars.
来自互联网
20. 故临床上有血热、血燥、血瘀、脓毒、风湿阻络、热毒伤阴六证之分。
It is hot, the clinical blood, blood stasis, blood, pus, thermal resistance rheumatism flashover poison Yin six card points.
来自互联网
21. 湿热阻络证（17.2%），苔黄腻为本型最重要的影响因素；
Syndrome of dampness-heat blocking collaterals (17.2%), yellow greasy furred tongue is the important factor;
来自互联网
22. 临床辨证将脂肪肝分为痰湿困脾、肝郁气滞、瘀浊阻络三个主要证型。
The clinical differentiation of signs divides fat liver into 3 main types: spleen afflicted with sputum dampness, depressed liver and Qi obstruction, turbid stasis obstructing collaterals.
来自互联网
23. 临床辨证将脂肪肝分为痰湿困脾、肝郁气滞、瘀浊阻络三个主要证型。
The clinical differentiation of signs divides fat liver into 3 main types: spleen afflicted with sputum dampness, depressed liver and Qi obstruction, turbid stasis obstructing collaterals.
